Tag: Covaxin

110 Countries Recognise India's Covishield, Covaxin: Source
110 Countries Recognise India's Covishield, Covaxin: Source

Of eight WHO-approved vaccines against Covid-19 in emergency use listing, two vaccines -- Covaxin and Covishield -- are from India.

  • Friday, 19 November 2021
 Covaxin
Covaxin 77.8% Effective Against COVID-19: Lancet study

The phase 3 trial Efficacy and Safety Study involving 25,800 volunteers across 25 sites in India is India's largest ever clinical trial conducted for a Covid-19 vaccine.

  • Friday, 12 November 2021
Covaxin
UK To Add India's Covaxin To Approved List From November 22

Covishield, the India-manufactured Oxford-AstraZeneca COVID-19 vaccine, was added to the UK's approved list last month.

  • Tuesday, 09 November 2021
Bharat Biotech's US Partner Ocugen Seeks Covaxin Approval For Kids
Bharat Biotech's US Partner Ocugen Seeks Covaxin Approval For Kids

Covaxin uses the same Vero Cell manufacturing platform as other childhood vaccines, including the inactivated polio vaccine.

  • Saturday, 06 November 2021
Finally Approved!
Covaxin Gets WHO Nod; Union Health Minister’s Reaction

Covaxin Gets WHO Nod; Union Health Minister’s Reaction

Video Icon
  • Wednesday, 03 November 2021
Bharat Biotech's Covaxin
Bharat Biotech's Covaxin gets WHO's nod

The World Health Organisation (WHO) granted Emergency Use Listing approval to India's indigenously-developed Covid vaccine, Bharat Biotech's Covaxin on Wednesday.

  • Wednesday, 03 November 2021
Covaxin
CDSCO approves extension of Covaxin's shelf life to 12 months

India's drug regulator, the Central Drugs Standards Control Organisation (CDSCO) has approved the extension of shelf life of indigenously-developed Covid-19 vaccine Covaxin from nine to 12 months.

  • Wednesday, 03 November 2021
Covaxin
After Australia, 5 More Countries Recognise India's Covaxin

Five more countries on Monday recognised India's vaccine certificate, after Australia recognised Bharat Biotech's Covaxin for allowing entry of travellers who had received the vaccine

  • Monday, 01 November 2021
Covaxin
Australia Recognises India's Covaxin

This recognition is for travellers aged 12 and over who have been vaccinated with Covaxin, and those 18 to 60 who have been vaccinated with BBIBP-CorV.

  • Monday, 01 November 2021
WHO Body Seeks More Clarification To Decide On Covaxin EUL
WHO Body Seeks More Clarification To Decide On Covaxin EUL

Hyderabad based Bharat Biotech is expected to submit the data by this weekend.

  • Wednesday, 27 October 2021
Bharat Biotech's Covaxin
WHO May Approve Bharat Biotech's Covaxin Within 24 Hours

The Hyderabad-based Bharat Biotech had applied to the WHO on April 19 for Covaxin's Emergency Use Listing

  • Tuesday, 26 October 2021
COVID-19 Vaccine
Don't Cast Doubt On Vaccination: SC Junks Plea Against Mass Vax Of Covishield, Covaxin

The top court told the petitioner's counsel that it finds no error with the high court decision in the matter, and it will not entertain the petition.

  • Monday, 25 October 2021
WHO To Meet Next Week To Consider Emergency Use Listing Of India's Covaxin
WHO To Meet Next Week To Consider Emergency Use Listing Of India's Covaxin

Bharat Biotech recently said it has submitted all data pertaining to Covaxin to the WHO for the EUL and is awaiting feedback from the global health watchdog.

  • Monday, 18 October 2021
Covaxin Approved
Finally, Covaxin Approved For Children In 2-18 Yrs Age Group, DCGI Gives Nod

The Drugs and Comptroller General of India (DCGI) has given a go-ahead to Bharat Biotech's Covaxin for vaccination of children in the 2-18 years age group.

Video Icon
  • Tuesday, 12 October 2021
 Covaxin
Covaxin Approved For Children In 2-18 Age Group

The Subject Expert Committee (SEC) has given the necessary approval for the administration of the anti-Covid vaccine to children.

  • Tuesday, 12 October 2021
scrollToTop